FDA Inspection 1275163 — Aesica Pharmaceuticals S.r.l.

Aesica Pharmaceuticals S.r.l. — FEI 3013548751

The FDA completed an inspection of Aesica Pharmaceuticals S.r.l. on May 30, 2025 in Pianezza. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 30, 2025
Fiscal Year
2025
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Pianezza (Italy)